Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs-Reference-Cited by-同舟云学术

Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs

Published:2010-08-12 Issue:3 Volume:85 Page:181-191
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Morabito Fortunato,Gentile Massimo,Mazzone Carla,Bringhen Sara,Vigna Ernesto,Lucia Eugenio,Recchia Anna G.,Raimondo Francesco D.,Musto Pellegrino,Palumbo Antonio

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2010.01472.x/fullpdf

Reference103 articles.

1. Diagnosis and management of multiple myeloma;UK Myeloma Forum. British Committee for Standards in Haematology;Br J Haematol,2001

2. Cancer statistics by race and ethnicity;Parker;CA Cancer J Clin,1998

3. Review of 1027 patients with newly diagnosed multiple myeloma;Kyle;Mayo Clin Proc,2003

4. The use of bisphosphonates in elderly cancer patients;Gridelli;Oncologist,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance;Apoptosis;2015-06-02

2. Long-term Follow-up of MRC Myeloma IX Trial: Survival Outcomes with Bisphosphonate and Thalidomide Treatment;Clinical Cancer Research;2013-08-30

3. Antimyeloma activity of NK012, a micelle-forming macromolecular prodrug of SN-38, in an orthotopic model;International Journal of Cancer;2013-07-16

4. Perspectives in the treatment of multiple myeloma;Expert Opinion on Biological Therapy;2013-05-22

5. MEK inhibitors as a chemotherapeutic intervention in multiple myeloma;Blood Cancer Journal;2013-03